Illumina has appointed Michael Sullivan as Chief Commercial Officer effective July 20, 2026, and Julie Coletti as Chief Legal Officer effective August 3, 2026. Sullivan brings more than 30 years of commercial leadership experience, most recently serving as Chief Commercial Officer at Caris Life Sciences, and will lead Illumina's global commercial organization. Coletti, previously Chief Legal and Regulatory Officer at Align Technology, will oversee global legal, regulatory, and government affairs teams and serve as corporate secretary. Both executives join Illumina's Executive Leadership Team as the company advances its strategy in genomics and multiomics.
Illumina IncAppointment of experienced commercial and legal leaders strengthens executive team, supporting strategic execution.
Caris Life Sciences, Inc. Common Stock
Align Technology Inc